Global Nucleic Acid Based Gene Therapy Market Growth (Status and Outlook) 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
Gene therapy is used for correcting defective genes that are responsible for disease development. Moreover, nucleic acid-based therapeutics are used to treat genetic disorders and diseases for which there exists no permanent cure such as anaemia, sickle cell, cystic fibrosis, diabetes, and thalassemia.
LPI (LP Information)' newest research report, the “Nucleic Acid Based Gene Therapy Industry Forecast” looks at past sales and reviews total world Nucleic Acid Based Gene Therapy sales in 2022, providing a comprehensive analysis by region and market sector of projected Nucleic Acid Based Gene Therapy sales for 2023 through 2029. With Nucleic Acid Based Gene Therapy sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Nucleic Acid Based Gene Therapy industry.
This Insight Report provides a comprehensive analysis of the global Nucleic Acid Based Gene Therapy landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Nucleic Acid Based Gene Therapy portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Nucleic Acid Based Gene Therapy market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Nucleic Acid Based Gene Therapy and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Nucleic Acid Based Gene Therapy.
The global Nucleic Acid Based Gene Therapy market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Nucleic Acid Based Gene Therapy is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Nucleic Acid Based Gene Therapy is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Nucleic Acid Based Gene Therapy is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Nucleic Acid Based Gene Therapy players cover Wave Life Sciences, Imugene, Sarepta Therapeutics, Alnylam Pharmaceuticals, Ionis Pharmaceuticals, Moderna, BioNTech, Nutcracker Therapeutics and Deep Genomics, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Nucleic Acid Based Gene Therapy market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
Gene therapy is used for correcting defective genes that are responsible for disease development. Moreover, nucleic acid-based therapeutics are used to treat genetic disorders and diseases for which there exists no permanent cure such as anaemia, sickle cell, cystic fibrosis, diabetes, and thalassemia.
LPI (LP Information)' newest research report, the “Nucleic Acid Based Gene Therapy Industry Forecast” looks at past sales and reviews total world Nucleic Acid Based Gene Therapy sales in 2022, providing a comprehensive analysis by region and market sector of projected Nucleic Acid Based Gene Therapy sales for 2023 through 2029. With Nucleic Acid Based Gene Therapy sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Nucleic Acid Based Gene Therapy industry.
This Insight Report provides a comprehensive analysis of the global Nucleic Acid Based Gene Therapy landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Nucleic Acid Based Gene Therapy portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Nucleic Acid Based Gene Therapy market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Nucleic Acid Based Gene Therapy and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Nucleic Acid Based Gene Therapy.
The global Nucleic Acid Based Gene Therapy market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Nucleic Acid Based Gene Therapy is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Nucleic Acid Based Gene Therapy is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Nucleic Acid Based Gene Therapy is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Nucleic Acid Based Gene Therapy players cover Wave Life Sciences, Imugene, Sarepta Therapeutics, Alnylam Pharmaceuticals, Ionis Pharmaceuticals, Moderna, BioNTech, Nutcracker Therapeutics and Deep Genomics, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Nucleic Acid Based Gene Therapy market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
- Anti-Sence and Anti-Gene
- Short Inhibitory Sequences
- Gene Transfer Therapy
- Nucleoside Analogs
- Ribozymes
- Aptamers
- Others
- Hospitals and Clinics
- Academic and Research Institutes
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Wave Life Sciences
- Imugene
- Sarepta Therapeutics
- Alnylam Pharmaceuticals
- Ionis Pharmaceuticals
- Moderna
- BioNTech
- Nutcracker Therapeutics
- Deep Genomics
- Sirnaomics
- Laronde
- Abogen Biosciences
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Nucleic Acid Based Gene Therapy Market Size 2018-2029
2.1.2 Nucleic Acid Based Gene Therapy Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Nucleic Acid Based Gene Therapy Segment by Type
2.2.1 Anti-Sence and Anti-Gene
2.2.2 Short Inhibitory Sequences
2.2.3 Gene Transfer Therapy
2.2.4 Nucleoside Analogs
2.2.5 Ribozymes
2.2.6 Aptamers
2.2.7 Others
2.3 Nucleic Acid Based Gene Therapy Market Size by Type
2.3.1 Nucleic Acid Based Gene Therapy Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Nucleic Acid Based Gene Therapy Market Size Market Share by Type (2018-2023)
2.4 Nucleic Acid Based Gene Therapy Segment by Application
2.4.1 Hospitals and Clinics
2.4.2 Academic and Research Institutes
2.4.3 Others
2.5 Nucleic Acid Based Gene Therapy Market Size by Application
2.5.1 Nucleic Acid Based Gene Therapy Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Nucleic Acid Based Gene Therapy Market Size Market Share by Application (2018-2023)
3 NUCLEIC ACID BASED GENE THERAPY MARKET SIZE BY PLAYER
3.1 Nucleic Acid Based Gene Therapy Market Size Market Share by Players
3.1.1 Global Nucleic Acid Based Gene Therapy Revenue by Players (2018-2023)
3.1.2 Global Nucleic Acid Based Gene Therapy Revenue Market Share by Players (2018-2023)
3.2 Global Nucleic Acid Based Gene Therapy Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 NUCLEIC ACID BASED GENE THERAPY BY REGIONS
4.1 Nucleic Acid Based Gene Therapy Market Size by Regions (2018-2023)
4.2 Americas Nucleic Acid Based Gene Therapy Market Size Growth (2018-2023)
4.3 APAC Nucleic Acid Based Gene Therapy Market Size Growth (2018-2023)
4.4 Europe Nucleic Acid Based Gene Therapy Market Size Growth (2018-2023)
4.5 Middle East & Africa Nucleic Acid Based Gene Therapy Market Size Growth (2018-2023)
5 AMERICAS
5.1 Americas Nucleic Acid Based Gene Therapy Market Size by Country (2018-2023)
5.2 Americas Nucleic Acid Based Gene Therapy Market Size by Type (2018-2023)
5.3 Americas Nucleic Acid Based Gene Therapy Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Nucleic Acid Based Gene Therapy Market Size by Region (2018-2023)
6.2 APAC Nucleic Acid Based Gene Therapy Market Size by Type (2018-2023)
6.3 APAC Nucleic Acid Based Gene Therapy Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Nucleic Acid Based Gene Therapy by Country (2018-2023)
7.2 Europe Nucleic Acid Based Gene Therapy Market Size by Type (2018-2023)
7.3 Europe Nucleic Acid Based Gene Therapy Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Nucleic Acid Based Gene Therapy by Region (2018-2023)
8.2 Middle East & Africa Nucleic Acid Based Gene Therapy Market Size by Type (2018-2023)
8.3 Middle East & Africa Nucleic Acid Based Gene Therapy Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL NUCLEIC ACID BASED GENE THERAPY MARKET FORECAST
10.1 Global Nucleic Acid Based Gene Therapy Forecast by Regions (2024-2029)
10.1.1 Global Nucleic Acid Based Gene Therapy Forecast by Regions (2024-2029)
10.1.2 Americas Nucleic Acid Based Gene Therapy Forecast
10.1.3 APAC Nucleic Acid Based Gene Therapy Forecast
10.1.4 Europe Nucleic Acid Based Gene Therapy Forecast
10.1.5 Middle East & Africa Nucleic Acid Based Gene Therapy Forecast
10.2 Americas Nucleic Acid Based Gene Therapy Forecast by Country (2024-2029)
10.2.1 United States Nucleic Acid Based Gene Therapy Market Forecast
10.2.2 Canada Nucleic Acid Based Gene Therapy Market Forecast
10.2.3 Mexico Nucleic Acid Based Gene Therapy Market Forecast
10.2.4 Brazil Nucleic Acid Based Gene Therapy Market Forecast
10.3 APAC Nucleic Acid Based Gene Therapy Forecast by Region (2024-2029)
10.3.1 China Nucleic Acid Based Gene Therapy Market Forecast
10.3.2 Japan Nucleic Acid Based Gene Therapy Market Forecast
10.3.3 Korea Nucleic Acid Based Gene Therapy Market Forecast
10.3.4 Southeast Asia Nucleic Acid Based Gene Therapy Market Forecast
10.3.5 India Nucleic Acid Based Gene Therapy Market Forecast
10.3.6 Australia Nucleic Acid Based Gene Therapy Market Forecast
10.4 Europe Nucleic Acid Based Gene Therapy Forecast by Country (2024-2029)
10.4.1 Germany Nucleic Acid Based Gene Therapy Market Forecast
10.4.2 France Nucleic Acid Based Gene Therapy Market Forecast
10.4.3 UK Nucleic Acid Based Gene Therapy Market Forecast
10.4.4 Italy Nucleic Acid Based Gene Therapy Market Forecast
10.4.5 Russia Nucleic Acid Based Gene Therapy Market Forecast
10.5 Middle East & Africa Nucleic Acid Based Gene Therapy Forecast by Region (2024-2029)
10.5.1 Egypt Nucleic Acid Based Gene Therapy Market Forecast
10.5.2 South Africa Nucleic Acid Based Gene Therapy Market Forecast
10.5.3 Israel Nucleic Acid Based Gene Therapy Market Forecast
10.5.4 Turkey Nucleic Acid Based Gene Therapy Market Forecast
10.5.5 GCC Countries Nucleic Acid Based Gene Therapy Market Forecast
10.6 Global Nucleic Acid Based Gene Therapy Forecast by Type (2024-2029)
10.7 Global Nucleic Acid Based Gene Therapy Forecast by Application (2024-2029)
11 KEY PLAYERS ANALYSIS
11.1 Wave Life Sciences
11.1.1 Wave Life Sciences Company Information
11.1.2 Wave Life Sciences Nucleic Acid Based Gene Therapy Product Offered
11.1.3 Wave Life Sciences Nucleic Acid Based Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Wave Life Sciences Main Business Overview
11.1.5 Wave Life Sciences Latest Developments
11.2 Imugene
11.2.1 Imugene Company Information
11.2.2 Imugene Nucleic Acid Based Gene Therapy Product Offered
11.2.3 Imugene Nucleic Acid Based Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Imugene Main Business Overview
11.2.5 Imugene Latest Developments
11.3 Sarepta Therapeutics
11.3.1 Sarepta Therapeutics Company Information
11.3.2 Sarepta Therapeutics Nucleic Acid Based Gene Therapy Product Offered
11.3.3 Sarepta Therapeutics Nucleic Acid Based Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Sarepta Therapeutics Main Business Overview
11.3.5 Sarepta Therapeutics Latest Developments
11.4 Alnylam Pharmaceuticals
11.4.1 Alnylam Pharmaceuticals Company Information
11.4.2 Alnylam Pharmaceuticals Nucleic Acid Based Gene Therapy Product Offered
11.4.3 Alnylam Pharmaceuticals Nucleic Acid Based Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Alnylam Pharmaceuticals Main Business Overview
11.4.5 Alnylam Pharmaceuticals Latest Developments
11.5 Ionis Pharmaceuticals
11.5.1 Ionis Pharmaceuticals Company Information
11.5.2 Ionis Pharmaceuticals Nucleic Acid Based Gene Therapy Product Offered
11.5.3 Ionis Pharmaceuticals Nucleic Acid Based Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Ionis Pharmaceuticals Main Business Overview
11.5.5 Ionis Pharmaceuticals Latest Developments
11.6 Moderna
11.6.1 Moderna Company Information
11.6.2 Moderna Nucleic Acid Based Gene Therapy Product Offered
11.6.3 Moderna Nucleic Acid Based Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 Moderna Main Business Overview
11.6.5 Moderna Latest Developments
11.7 BioNTech
11.7.1 BioNTech Company Information
11.7.2 BioNTech Nucleic Acid Based Gene Therapy Product Offered
11.7.3 BioNTech Nucleic Acid Based Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 BioNTech Main Business Overview
11.7.5 BioNTech Latest Developments
11.8 Nutcracker Therapeutics
11.8.1 Nutcracker Therapeutics Company Information
11.8.2 Nutcracker Therapeutics Nucleic Acid Based Gene Therapy Product Offered
11.8.3 Nutcracker Therapeutics Nucleic Acid Based Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 Nutcracker Therapeutics Main Business Overview
11.8.5 Nutcracker Therapeutics Latest Developments
11.9 Deep Genomics
11.9.1 Deep Genomics Company Information
11.9.2 Deep Genomics Nucleic Acid Based Gene Therapy Product Offered
11.9.3 Deep Genomics Nucleic Acid Based Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 Deep Genomics Main Business Overview
11.9.5 Deep Genomics Latest Developments
11.10 Sirnaomics
11.10.1 Sirnaomics Company Information
11.10.2 Sirnaomics Nucleic Acid Based Gene Therapy Product Offered
11.10.3 Sirnaomics Nucleic Acid Based Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 Sirnaomics Main Business Overview
11.10.5 Sirnaomics Latest Developments
11.11 Laronde
11.11.1 Laronde Company Information
11.11.2 Laronde Nucleic Acid Based Gene Therapy Product Offered
11.11.3 Laronde Nucleic Acid Based Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.11.4 Laronde Main Business Overview
11.11.5 Laronde Latest Developments
11.12 Abogen Biosciences
11.12.1 Abogen Biosciences Company Information
11.12.2 Abogen Biosciences Nucleic Acid Based Gene Therapy Product Offered
11.12.3 Abogen Biosciences Nucleic Acid Based Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.12.4 Abogen Biosciences Main Business Overview
11.12.5 Abogen Biosciences Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Nucleic Acid Based Gene Therapy Market Size 2018-2029
2.1.2 Nucleic Acid Based Gene Therapy Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Nucleic Acid Based Gene Therapy Segment by Type
2.2.1 Anti-Sence and Anti-Gene
2.2.2 Short Inhibitory Sequences
2.2.3 Gene Transfer Therapy
2.2.4 Nucleoside Analogs
2.2.5 Ribozymes
2.2.6 Aptamers
2.2.7 Others
2.3 Nucleic Acid Based Gene Therapy Market Size by Type
2.3.1 Nucleic Acid Based Gene Therapy Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Nucleic Acid Based Gene Therapy Market Size Market Share by Type (2018-2023)
2.4 Nucleic Acid Based Gene Therapy Segment by Application
2.4.1 Hospitals and Clinics
2.4.2 Academic and Research Institutes
2.4.3 Others
2.5 Nucleic Acid Based Gene Therapy Market Size by Application
2.5.1 Nucleic Acid Based Gene Therapy Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Nucleic Acid Based Gene Therapy Market Size Market Share by Application (2018-2023)
3 NUCLEIC ACID BASED GENE THERAPY MARKET SIZE BY PLAYER
3.1 Nucleic Acid Based Gene Therapy Market Size Market Share by Players
3.1.1 Global Nucleic Acid Based Gene Therapy Revenue by Players (2018-2023)
3.1.2 Global Nucleic Acid Based Gene Therapy Revenue Market Share by Players (2018-2023)
3.2 Global Nucleic Acid Based Gene Therapy Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 NUCLEIC ACID BASED GENE THERAPY BY REGIONS
4.1 Nucleic Acid Based Gene Therapy Market Size by Regions (2018-2023)
4.2 Americas Nucleic Acid Based Gene Therapy Market Size Growth (2018-2023)
4.3 APAC Nucleic Acid Based Gene Therapy Market Size Growth (2018-2023)
4.4 Europe Nucleic Acid Based Gene Therapy Market Size Growth (2018-2023)
4.5 Middle East & Africa Nucleic Acid Based Gene Therapy Market Size Growth (2018-2023)
5 AMERICAS
5.1 Americas Nucleic Acid Based Gene Therapy Market Size by Country (2018-2023)
5.2 Americas Nucleic Acid Based Gene Therapy Market Size by Type (2018-2023)
5.3 Americas Nucleic Acid Based Gene Therapy Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Nucleic Acid Based Gene Therapy Market Size by Region (2018-2023)
6.2 APAC Nucleic Acid Based Gene Therapy Market Size by Type (2018-2023)
6.3 APAC Nucleic Acid Based Gene Therapy Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Nucleic Acid Based Gene Therapy by Country (2018-2023)
7.2 Europe Nucleic Acid Based Gene Therapy Market Size by Type (2018-2023)
7.3 Europe Nucleic Acid Based Gene Therapy Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Nucleic Acid Based Gene Therapy by Region (2018-2023)
8.2 Middle East & Africa Nucleic Acid Based Gene Therapy Market Size by Type (2018-2023)
8.3 Middle East & Africa Nucleic Acid Based Gene Therapy Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL NUCLEIC ACID BASED GENE THERAPY MARKET FORECAST
10.1 Global Nucleic Acid Based Gene Therapy Forecast by Regions (2024-2029)
10.1.1 Global Nucleic Acid Based Gene Therapy Forecast by Regions (2024-2029)
10.1.2 Americas Nucleic Acid Based Gene Therapy Forecast
10.1.3 APAC Nucleic Acid Based Gene Therapy Forecast
10.1.4 Europe Nucleic Acid Based Gene Therapy Forecast
10.1.5 Middle East & Africa Nucleic Acid Based Gene Therapy Forecast
10.2 Americas Nucleic Acid Based Gene Therapy Forecast by Country (2024-2029)
10.2.1 United States Nucleic Acid Based Gene Therapy Market Forecast
10.2.2 Canada Nucleic Acid Based Gene Therapy Market Forecast
10.2.3 Mexico Nucleic Acid Based Gene Therapy Market Forecast
10.2.4 Brazil Nucleic Acid Based Gene Therapy Market Forecast
10.3 APAC Nucleic Acid Based Gene Therapy Forecast by Region (2024-2029)
10.3.1 China Nucleic Acid Based Gene Therapy Market Forecast
10.3.2 Japan Nucleic Acid Based Gene Therapy Market Forecast
10.3.3 Korea Nucleic Acid Based Gene Therapy Market Forecast
10.3.4 Southeast Asia Nucleic Acid Based Gene Therapy Market Forecast
10.3.5 India Nucleic Acid Based Gene Therapy Market Forecast
10.3.6 Australia Nucleic Acid Based Gene Therapy Market Forecast
10.4 Europe Nucleic Acid Based Gene Therapy Forecast by Country (2024-2029)
10.4.1 Germany Nucleic Acid Based Gene Therapy Market Forecast
10.4.2 France Nucleic Acid Based Gene Therapy Market Forecast
10.4.3 UK Nucleic Acid Based Gene Therapy Market Forecast
10.4.4 Italy Nucleic Acid Based Gene Therapy Market Forecast
10.4.5 Russia Nucleic Acid Based Gene Therapy Market Forecast
10.5 Middle East & Africa Nucleic Acid Based Gene Therapy Forecast by Region (2024-2029)
10.5.1 Egypt Nucleic Acid Based Gene Therapy Market Forecast
10.5.2 South Africa Nucleic Acid Based Gene Therapy Market Forecast
10.5.3 Israel Nucleic Acid Based Gene Therapy Market Forecast
10.5.4 Turkey Nucleic Acid Based Gene Therapy Market Forecast
10.5.5 GCC Countries Nucleic Acid Based Gene Therapy Market Forecast
10.6 Global Nucleic Acid Based Gene Therapy Forecast by Type (2024-2029)
10.7 Global Nucleic Acid Based Gene Therapy Forecast by Application (2024-2029)
11 KEY PLAYERS ANALYSIS
11.1 Wave Life Sciences
11.1.1 Wave Life Sciences Company Information
11.1.2 Wave Life Sciences Nucleic Acid Based Gene Therapy Product Offered
11.1.3 Wave Life Sciences Nucleic Acid Based Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Wave Life Sciences Main Business Overview
11.1.5 Wave Life Sciences Latest Developments
11.2 Imugene
11.2.1 Imugene Company Information
11.2.2 Imugene Nucleic Acid Based Gene Therapy Product Offered
11.2.3 Imugene Nucleic Acid Based Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Imugene Main Business Overview
11.2.5 Imugene Latest Developments
11.3 Sarepta Therapeutics
11.3.1 Sarepta Therapeutics Company Information
11.3.2 Sarepta Therapeutics Nucleic Acid Based Gene Therapy Product Offered
11.3.3 Sarepta Therapeutics Nucleic Acid Based Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Sarepta Therapeutics Main Business Overview
11.3.5 Sarepta Therapeutics Latest Developments
11.4 Alnylam Pharmaceuticals
11.4.1 Alnylam Pharmaceuticals Company Information
11.4.2 Alnylam Pharmaceuticals Nucleic Acid Based Gene Therapy Product Offered
11.4.3 Alnylam Pharmaceuticals Nucleic Acid Based Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Alnylam Pharmaceuticals Main Business Overview
11.4.5 Alnylam Pharmaceuticals Latest Developments
11.5 Ionis Pharmaceuticals
11.5.1 Ionis Pharmaceuticals Company Information
11.5.2 Ionis Pharmaceuticals Nucleic Acid Based Gene Therapy Product Offered
11.5.3 Ionis Pharmaceuticals Nucleic Acid Based Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Ionis Pharmaceuticals Main Business Overview
11.5.5 Ionis Pharmaceuticals Latest Developments
11.6 Moderna
11.6.1 Moderna Company Information
11.6.2 Moderna Nucleic Acid Based Gene Therapy Product Offered
11.6.3 Moderna Nucleic Acid Based Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 Moderna Main Business Overview
11.6.5 Moderna Latest Developments
11.7 BioNTech
11.7.1 BioNTech Company Information
11.7.2 BioNTech Nucleic Acid Based Gene Therapy Product Offered
11.7.3 BioNTech Nucleic Acid Based Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 BioNTech Main Business Overview
11.7.5 BioNTech Latest Developments
11.8 Nutcracker Therapeutics
11.8.1 Nutcracker Therapeutics Company Information
11.8.2 Nutcracker Therapeutics Nucleic Acid Based Gene Therapy Product Offered
11.8.3 Nutcracker Therapeutics Nucleic Acid Based Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 Nutcracker Therapeutics Main Business Overview
11.8.5 Nutcracker Therapeutics Latest Developments
11.9 Deep Genomics
11.9.1 Deep Genomics Company Information
11.9.2 Deep Genomics Nucleic Acid Based Gene Therapy Product Offered
11.9.3 Deep Genomics Nucleic Acid Based Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 Deep Genomics Main Business Overview
11.9.5 Deep Genomics Latest Developments
11.10 Sirnaomics
11.10.1 Sirnaomics Company Information
11.10.2 Sirnaomics Nucleic Acid Based Gene Therapy Product Offered
11.10.3 Sirnaomics Nucleic Acid Based Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 Sirnaomics Main Business Overview
11.10.5 Sirnaomics Latest Developments
11.11 Laronde
11.11.1 Laronde Company Information
11.11.2 Laronde Nucleic Acid Based Gene Therapy Product Offered
11.11.3 Laronde Nucleic Acid Based Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.11.4 Laronde Main Business Overview
11.11.5 Laronde Latest Developments
11.12 Abogen Biosciences
11.12.1 Abogen Biosciences Company Information
11.12.2 Abogen Biosciences Nucleic Acid Based Gene Therapy Product Offered
11.12.3 Abogen Biosciences Nucleic Acid Based Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.12.4 Abogen Biosciences Main Business Overview
11.12.5 Abogen Biosciences Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Nucleic Acid Based Gene Therapy Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Anti-Sence and Anti-Gene
Table 3. Major Players of Short Inhibitory Sequences
Table 4. Major Players of Gene Transfer Therapy
Table 5. Major Players of Nucleoside Analogs
Table 6. Major Players of Ribozymes
Table 7. Major Players of Aptamers
Table 8. Major Players of Others
Table 9. Nucleic Acid Based Gene Therapy Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 10. Global Nucleic Acid Based Gene Therapy Market Size by Type (2018-2023) & ($ Millions)
Table 11. Global Nucleic Acid Based Gene Therapy Market Size Market Share by Type (2018-2023)
Table 12. Nucleic Acid Based Gene Therapy Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 13. Global Nucleic Acid Based Gene Therapy Market Size by Application (2018-2023) & ($ Millions)
Table 14. Global Nucleic Acid Based Gene Therapy Market Size Market Share by Application (2018-2023)
Table 15. Global Nucleic Acid Based Gene Therapy Revenue by Players (2018-2023) & ($ Millions)
Table 16. Global Nucleic Acid Based Gene Therapy Revenue Market Share by Player (2018-2023)
Table 17. Nucleic Acid Based Gene Therapy Key Players Head office and Products Offered
Table 18. Nucleic Acid Based Gene Therapy Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 19. New Products and Potential Entrants
Table 20. Mergers & Acquisitions, Expansion
Table 21. Global Nucleic Acid Based Gene Therapy Market Size by Regions 2018-2023 & ($ Millions)
Table 22. Global Nucleic Acid Based Gene Therapy Market Size Market Share by Regions (2018-2023)
Table 23. Global Nucleic Acid Based Gene Therapy Revenue by Country/Region (2018-2023) & ($ millions)
Table 24. Global Nucleic Acid Based Gene Therapy Revenue Market Share by Country/Region (2018-2023)
Table 25. Americas Nucleic Acid Based Gene Therapy Market Size by Country (2018-2023) & ($ Millions)
Table 26. Americas Nucleic Acid Based Gene Therapy Market Size Market Share by Country (2018-2023)
Table 27. Americas Nucleic Acid Based Gene Therapy Market Size by Type (2018-2023) & ($ Millions)
Table 28. Americas Nucleic Acid Based Gene Therapy Market Size Market Share by Type (2018-2023)
Table 29. Americas Nucleic Acid Based Gene Therapy Market Size by Application (2018-2023) & ($ Millions)
Table 30. Americas Nucleic Acid Based Gene Therapy Market Size Market Share by Application (2018-2023)
Table 31. APAC Nucleic Acid Based Gene Therapy Market Size by Region (2018-2023) & ($ Millions)
Table 32. APAC Nucleic Acid Based Gene Therapy Market Size Market Share by Region (2018-2023)
Table 33. APAC Nucleic Acid Based Gene Therapy Market Size by Type (2018-2023) & ($ Millions)
Table 34. APAC Nucleic Acid Based Gene Therapy Market Size Market Share by Type (2018-2023)
Table 35. APAC Nucleic Acid Based Gene Therapy Market Size by Application (2018-2023) & ($ Millions)
Table 36. APAC Nucleic Acid Based Gene Therapy Market Size Market Share by Application (2018-2023)
Table 37. Europe Nucleic Acid Based Gene Therapy Market Size by Country (2018-2023) & ($ Millions)
Table 38. Europe Nucleic Acid Based Gene Therapy Market Size Market Share by Country (2018-2023)
Table 39. Europe Nucleic Acid Based Gene Therapy Market Size by Type (2018-2023) & ($ Millions)
Table 40. Europe Nucleic Acid Based Gene Therapy Market Size Market Share by Type (2018-2023)
Table 41. Europe Nucleic Acid Based Gene Therapy Market Size by Application (2018-2023) & ($ Millions)
Table 42. Europe Nucleic Acid Based Gene Therapy Market Size Market Share by Application (2018-2023)
Table 43. Middle East & Africa Nucleic Acid Based Gene Therapy Market Size by Region (2018-2023) & ($ Millions)
Table 44. Middle East & Africa Nucleic Acid Based Gene Therapy Market Size Market Share by Region (2018-2023)
Table 45. Middle East & Africa Nucleic Acid Based Gene Therapy Market Size by Type (2018-2023) & ($ Millions)
Table 46. Middle East & Africa Nucleic Acid Based Gene Therapy Market Size Market Share by Type (2018-2023)
Table 47. Middle East & Africa Nucleic Acid Based Gene Therapy Market Size by Application (2018-2023) & ($ Millions)
Table 48. Middle East & Africa Nucleic Acid Based Gene Therapy Market Size Market Share by Application (2018-2023)
Table 49. Key Market Drivers & Growth Opportunities of Nucleic Acid Based Gene Therapy
Table 50. Key Market Challenges & Risks of Nucleic Acid Based Gene Therapy
Table 51. Key Industry Trends of Nucleic Acid Based Gene Therapy
Table 52. Global Nucleic Acid Based Gene Therapy Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 53. Global Nucleic Acid Based Gene Therapy Market Size Market Share Forecast by Regions (2024-2029)
Table 54. Global Nucleic Acid Based Gene Therapy Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 55. Global Nucleic Acid Based Gene Therapy Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 56. Wave Life Sciences Details, Company Type, Nucleic Acid Based Gene Therapy Area Served and Its Competitors
Table 57. Wave Life Sciences Nucleic Acid Based Gene Therapy Product Offered
Table 58. Wave Life Sciences Nucleic Acid Based Gene Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 59. Wave Life Sciences Main Business
Table 60. Wave Life Sciences Latest Developments
Table 61. Imugene Details, Company Type, Nucleic Acid Based Gene Therapy Area Served and Its Competitors
Table 62. Imugene Nucleic Acid Based Gene Therapy Product Offered
Table 63. Imugene Main Business
Table 64. Imugene Nucleic Acid Based Gene Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 65. Imugene Latest Developments
Table 66. Sarepta Therapeutics Details, Company Type, Nucleic Acid Based Gene Therapy Area Served and Its Competitors
Table 67. Sarepta Therapeutics Nucleic Acid Based Gene Therapy Product Offered
Table 68. Sarepta Therapeutics Main Business
Table 69. Sarepta Therapeutics Nucleic Acid Based Gene Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 70. Sarepta Therapeutics Latest Developments
Table 71. Alnylam Pharmaceuticals Details, Company Type, Nucleic Acid Based Gene Therapy Area Served and Its Competitors
Table 72. Alnylam Pharmaceuticals Nucleic Acid Based Gene Therapy Product Offered
Table 73. Alnylam Pharmaceuticals Main Business
Table 74. Alnylam Pharmaceuticals Nucleic Acid Based Gene Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 75. Alnylam Pharmaceuticals Latest Developments
Table 76. Ionis Pharmaceuticals Details, Company Type, Nucleic Acid Based Gene Therapy Area Served and Its Competitors
Table 77. Ionis Pharmaceuticals Nucleic Acid Based Gene Therapy Product Offered
Table 78. Ionis Pharmaceuticals Main Business
Table 79. Ionis Pharmaceuticals Nucleic Acid Based Gene Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 80. Ionis Pharmaceuticals Latest Developments
Table 81. Moderna Details, Company Type, Nucleic Acid Based Gene Therapy Area Served and Its Competitors
Table 82. Moderna Nucleic Acid Based Gene Therapy Product Offered
Table 83. Moderna Main Business
Table 84. Moderna Nucleic Acid Based Gene Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 85. Moderna Latest Developments
Table 86. BioNTech Details, Company Type, Nucleic Acid Based Gene Therapy Area Served and Its Competitors
Table 87. BioNTech Nucleic Acid Based Gene Therapy Product Offered
Table 88. BioNTech Main Business
Table 89. BioNTech Nucleic Acid Based Gene Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 90. BioNTech Latest Developments
Table 91. Nutcracker Therapeutics Details, Company Type, Nucleic Acid Based Gene Therapy Area Served and Its Competitors
Table 92. Nutcracker Therapeutics Nucleic Acid Based Gene Therapy Product Offered
Table 93. Nutcracker Therapeutics Main Business
Table 94. Nutcracker Therapeutics Nucleic Acid Based Gene Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 95. Nutcracker Therapeutics Latest Developments
Table 96. Deep Genomics Details, Company Type, Nucleic Acid Based Gene Therapy Area Served and Its Competitors
Table 97. Deep Genomics Nucleic Acid Based Gene Therapy Product Offered
Table 98. Deep Genomics Main Business
Table 99. Deep Genomics Nucleic Acid Based Gene Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 100. Deep Genomics Latest Developments
Table 101. Sirnaomics Details, Company Type, Nucleic Acid Based Gene Therapy Area Served and Its Competitors
Table 102. Sirnaomics Nucleic Acid Based Gene Therapy Product Offered
Table 103. Sirnaomics Main Business
Table 104. Sirnaomics Nucleic Acid Based Gene Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 105. Sirnaomics Latest Developments
Table 106. Laronde Details, Company Type, Nucleic Acid Based Gene Therapy Area Served and Its Competitors
Table 107. Laronde Nucleic Acid Based Gene Therapy Product Offered
Table 108. Laronde Nucleic Acid Based Gene Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 109. Laronde Main Business
Table 110. Laronde Latest Developments
Table 111. Abogen Biosciences Details, Company Type, Nucleic Acid Based Gene Therapy Area Served and Its Competitors
Table 112. Abogen Biosciences Nucleic Acid Based Gene Therapy Product Offered
Table 113. Abogen Biosciences Main Business
Table 114. Abogen Biosciences Nucleic Acid Based Gene Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 115. Abogen Biosciences Latest Developments
Table 1. Nucleic Acid Based Gene Therapy Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Anti-Sence and Anti-Gene
Table 3. Major Players of Short Inhibitory Sequences
Table 4. Major Players of Gene Transfer Therapy
Table 5. Major Players of Nucleoside Analogs
Table 6. Major Players of Ribozymes
Table 7. Major Players of Aptamers
Table 8. Major Players of Others
Table 9. Nucleic Acid Based Gene Therapy Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 10. Global Nucleic Acid Based Gene Therapy Market Size by Type (2018-2023) & ($ Millions)
Table 11. Global Nucleic Acid Based Gene Therapy Market Size Market Share by Type (2018-2023)
Table 12. Nucleic Acid Based Gene Therapy Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 13. Global Nucleic Acid Based Gene Therapy Market Size by Application (2018-2023) & ($ Millions)
Table 14. Global Nucleic Acid Based Gene Therapy Market Size Market Share by Application (2018-2023)
Table 15. Global Nucleic Acid Based Gene Therapy Revenue by Players (2018-2023) & ($ Millions)
Table 16. Global Nucleic Acid Based Gene Therapy Revenue Market Share by Player (2018-2023)
Table 17. Nucleic Acid Based Gene Therapy Key Players Head office and Products Offered
Table 18. Nucleic Acid Based Gene Therapy Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 19. New Products and Potential Entrants
Table 20. Mergers & Acquisitions, Expansion
Table 21. Global Nucleic Acid Based Gene Therapy Market Size by Regions 2018-2023 & ($ Millions)
Table 22. Global Nucleic Acid Based Gene Therapy Market Size Market Share by Regions (2018-2023)
Table 23. Global Nucleic Acid Based Gene Therapy Revenue by Country/Region (2018-2023) & ($ millions)
Table 24. Global Nucleic Acid Based Gene Therapy Revenue Market Share by Country/Region (2018-2023)
Table 25. Americas Nucleic Acid Based Gene Therapy Market Size by Country (2018-2023) & ($ Millions)
Table 26. Americas Nucleic Acid Based Gene Therapy Market Size Market Share by Country (2018-2023)
Table 27. Americas Nucleic Acid Based Gene Therapy Market Size by Type (2018-2023) & ($ Millions)
Table 28. Americas Nucleic Acid Based Gene Therapy Market Size Market Share by Type (2018-2023)
Table 29. Americas Nucleic Acid Based Gene Therapy Market Size by Application (2018-2023) & ($ Millions)
Table 30. Americas Nucleic Acid Based Gene Therapy Market Size Market Share by Application (2018-2023)
Table 31. APAC Nucleic Acid Based Gene Therapy Market Size by Region (2018-2023) & ($ Millions)
Table 32. APAC Nucleic Acid Based Gene Therapy Market Size Market Share by Region (2018-2023)
Table 33. APAC Nucleic Acid Based Gene Therapy Market Size by Type (2018-2023) & ($ Millions)
Table 34. APAC Nucleic Acid Based Gene Therapy Market Size Market Share by Type (2018-2023)
Table 35. APAC Nucleic Acid Based Gene Therapy Market Size by Application (2018-2023) & ($ Millions)
Table 36. APAC Nucleic Acid Based Gene Therapy Market Size Market Share by Application (2018-2023)
Table 37. Europe Nucleic Acid Based Gene Therapy Market Size by Country (2018-2023) & ($ Millions)
Table 38. Europe Nucleic Acid Based Gene Therapy Market Size Market Share by Country (2018-2023)
Table 39. Europe Nucleic Acid Based Gene Therapy Market Size by Type (2018-2023) & ($ Millions)
Table 40. Europe Nucleic Acid Based Gene Therapy Market Size Market Share by Type (2018-2023)
Table 41. Europe Nucleic Acid Based Gene Therapy Market Size by Application (2018-2023) & ($ Millions)
Table 42. Europe Nucleic Acid Based Gene Therapy Market Size Market Share by Application (2018-2023)
Table 43. Middle East & Africa Nucleic Acid Based Gene Therapy Market Size by Region (2018-2023) & ($ Millions)
Table 44. Middle East & Africa Nucleic Acid Based Gene Therapy Market Size Market Share by Region (2018-2023)
Table 45. Middle East & Africa Nucleic Acid Based Gene Therapy Market Size by Type (2018-2023) & ($ Millions)
Table 46. Middle East & Africa Nucleic Acid Based Gene Therapy Market Size Market Share by Type (2018-2023)
Table 47. Middle East & Africa Nucleic Acid Based Gene Therapy Market Size by Application (2018-2023) & ($ Millions)
Table 48. Middle East & Africa Nucleic Acid Based Gene Therapy Market Size Market Share by Application (2018-2023)
Table 49. Key Market Drivers & Growth Opportunities of Nucleic Acid Based Gene Therapy
Table 50. Key Market Challenges & Risks of Nucleic Acid Based Gene Therapy
Table 51. Key Industry Trends of Nucleic Acid Based Gene Therapy
Table 52. Global Nucleic Acid Based Gene Therapy Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 53. Global Nucleic Acid Based Gene Therapy Market Size Market Share Forecast by Regions (2024-2029)
Table 54. Global Nucleic Acid Based Gene Therapy Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 55. Global Nucleic Acid Based Gene Therapy Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 56. Wave Life Sciences Details, Company Type, Nucleic Acid Based Gene Therapy Area Served and Its Competitors
Table 57. Wave Life Sciences Nucleic Acid Based Gene Therapy Product Offered
Table 58. Wave Life Sciences Nucleic Acid Based Gene Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 59. Wave Life Sciences Main Business
Table 60. Wave Life Sciences Latest Developments
Table 61. Imugene Details, Company Type, Nucleic Acid Based Gene Therapy Area Served and Its Competitors
Table 62. Imugene Nucleic Acid Based Gene Therapy Product Offered
Table 63. Imugene Main Business
Table 64. Imugene Nucleic Acid Based Gene Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 65. Imugene Latest Developments
Table 66. Sarepta Therapeutics Details, Company Type, Nucleic Acid Based Gene Therapy Area Served and Its Competitors
Table 67. Sarepta Therapeutics Nucleic Acid Based Gene Therapy Product Offered
Table 68. Sarepta Therapeutics Main Business
Table 69. Sarepta Therapeutics Nucleic Acid Based Gene Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 70. Sarepta Therapeutics Latest Developments
Table 71. Alnylam Pharmaceuticals Details, Company Type, Nucleic Acid Based Gene Therapy Area Served and Its Competitors
Table 72. Alnylam Pharmaceuticals Nucleic Acid Based Gene Therapy Product Offered
Table 73. Alnylam Pharmaceuticals Main Business
Table 74. Alnylam Pharmaceuticals Nucleic Acid Based Gene Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 75. Alnylam Pharmaceuticals Latest Developments
Table 76. Ionis Pharmaceuticals Details, Company Type, Nucleic Acid Based Gene Therapy Area Served and Its Competitors
Table 77. Ionis Pharmaceuticals Nucleic Acid Based Gene Therapy Product Offered
Table 78. Ionis Pharmaceuticals Main Business
Table 79. Ionis Pharmaceuticals Nucleic Acid Based Gene Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 80. Ionis Pharmaceuticals Latest Developments
Table 81. Moderna Details, Company Type, Nucleic Acid Based Gene Therapy Area Served and Its Competitors
Table 82. Moderna Nucleic Acid Based Gene Therapy Product Offered
Table 83. Moderna Main Business
Table 84. Moderna Nucleic Acid Based Gene Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 85. Moderna Latest Developments
Table 86. BioNTech Details, Company Type, Nucleic Acid Based Gene Therapy Area Served and Its Competitors
Table 87. BioNTech Nucleic Acid Based Gene Therapy Product Offered
Table 88. BioNTech Main Business
Table 89. BioNTech Nucleic Acid Based Gene Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 90. BioNTech Latest Developments
Table 91. Nutcracker Therapeutics Details, Company Type, Nucleic Acid Based Gene Therapy Area Served and Its Competitors
Table 92. Nutcracker Therapeutics Nucleic Acid Based Gene Therapy Product Offered
Table 93. Nutcracker Therapeutics Main Business
Table 94. Nutcracker Therapeutics Nucleic Acid Based Gene Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 95. Nutcracker Therapeutics Latest Developments
Table 96. Deep Genomics Details, Company Type, Nucleic Acid Based Gene Therapy Area Served and Its Competitors
Table 97. Deep Genomics Nucleic Acid Based Gene Therapy Product Offered
Table 98. Deep Genomics Main Business
Table 99. Deep Genomics Nucleic Acid Based Gene Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 100. Deep Genomics Latest Developments
Table 101. Sirnaomics Details, Company Type, Nucleic Acid Based Gene Therapy Area Served and Its Competitors
Table 102. Sirnaomics Nucleic Acid Based Gene Therapy Product Offered
Table 103. Sirnaomics Main Business
Table 104. Sirnaomics Nucleic Acid Based Gene Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 105. Sirnaomics Latest Developments
Table 106. Laronde Details, Company Type, Nucleic Acid Based Gene Therapy Area Served and Its Competitors
Table 107. Laronde Nucleic Acid Based Gene Therapy Product Offered
Table 108. Laronde Nucleic Acid Based Gene Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 109. Laronde Main Business
Table 110. Laronde Latest Developments
Table 111. Abogen Biosciences Details, Company Type, Nucleic Acid Based Gene Therapy Area Served and Its Competitors
Table 112. Abogen Biosciences Nucleic Acid Based Gene Therapy Product Offered
Table 113. Abogen Biosciences Main Business
Table 114. Abogen Biosciences Nucleic Acid Based Gene Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 115. Abogen Biosciences Latest Developments
LIST OF FIGURES
Figure 1. Nucleic Acid Based Gene Therapy Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Nucleic Acid Based Gene Therapy Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Nucleic Acid Based Gene Therapy Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Nucleic Acid Based Gene Therapy Sales Market Share by Country/Region (2022)
Figure 8. Nucleic Acid Based Gene Therapy Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Nucleic Acid Based Gene Therapy Market Size Market Share by Type in 2022
Figure 10. Nucleic Acid Based Gene Therapy in Hospitals and Clinics
Figure 11. Global Nucleic Acid Based Gene Therapy Market: Hospitals and Clinics (2018-2023) & ($ Millions)
Figure 12. Nucleic Acid Based Gene Therapy in Academic and Research Institutes
Figure 13. Global Nucleic Acid Based Gene Therapy Market: Academic and Research Institutes (2018-2023) & ($ Millions)
Figure 14. Nucleic Acid Based Gene Therapy in Others
Figure 15. Global Nucleic Acid Based Gene Therapy Market: Others (2018-2023) & ($ Millions)
Figure 16. Global Nucleic Acid Based Gene Therapy Market Size Market Share by Application in 2022
Figure 17. Global Nucleic Acid Based Gene Therapy Revenue Market Share by Player in 2022
Figure 18. Global Nucleic Acid Based Gene Therapy Market Size Market Share by Regions (2018-2023)
Figure 19. Americas Nucleic Acid Based Gene Therapy Market Size 2018-2023 ($ Millions)
Figure 20. APAC Nucleic Acid Based Gene Therapy Market Size 2018-2023 ($ Millions)
Figure 21. Europe Nucleic Acid Based Gene Therapy Market Size 2018-2023 ($ Millions)
Figure 22. Middle East & Africa Nucleic Acid Based Gene Therapy Market Size 2018-2023 ($ Millions)
Figure 23. Americas Nucleic Acid Based Gene Therapy Value Market Share by Country in 2022
Figure 24. United States Nucleic Acid Based Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 25. Canada Nucleic Acid Based Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 26. Mexico Nucleic Acid Based Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 27. Brazil Nucleic Acid Based Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 28. APAC Nucleic Acid Based Gene Therapy Market Size Market Share by Region in 2022
Figure 29. APAC Nucleic Acid Based Gene Therapy Market Size Market Share by Type in 2022
Figure 30. APAC Nucleic Acid Based Gene Therapy Market Size Market Share by Application in 2022
Figure 31. China Nucleic Acid Based Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 32. Japan Nucleic Acid Based Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 33. Korea Nucleic Acid Based Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 34. Southeast Asia Nucleic Acid Based Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 35. India Nucleic Acid Based Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 36. Australia Nucleic Acid Based Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 37. Europe Nucleic Acid Based Gene Therapy Market Size Market Share by Country in 2022
Figure 38. Europe Nucleic Acid Based Gene Therapy Market Size Market Share by Type (2018-2023)
Figure 39. Europe Nucleic Acid Based Gene Therapy Market Size Market Share by Application (2018-2023)
Figure 40. Germany Nucleic Acid Based Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 41. France Nucleic Acid Based Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 42. UK Nucleic Acid Based Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 43. Italy Nucleic Acid Based Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 44. Russia Nucleic Acid Based Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 45. Middle East & Africa Nucleic Acid Based Gene Therapy Market Size Market Share by Region (2018-2023)
Figure 46. Middle East & Africa Nucleic Acid Based Gene Therapy Market Size Market Share by Type (2018-2023)
Figure 47. Middle East & Africa Nucleic Acid Based Gene Therapy Market Size Market Share by Application (2018-2023)
Figure 48. Egypt Nucleic Acid Based Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 49. South Africa Nucleic Acid Based Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 50. Israel Nucleic Acid Based Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 51. Turkey Nucleic Acid Based Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 52. GCC Country Nucleic Acid Based Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 53. Americas Nucleic Acid Based Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 54. APAC Nucleic Acid Based Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 55. Europe Nucleic Acid Based Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 56. Middle East & Africa Nucleic Acid Based Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 57. United States Nucleic Acid Based Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 58. Canada Nucleic Acid Based Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 59. Mexico Nucleic Acid Based Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 60. Brazil Nucleic Acid Based Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 61. China Nucleic Acid Based Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 62. Japan Nucleic Acid Based Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 63. Korea Nucleic Acid Based Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 64. Southeast Asia Nucleic Acid Based Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 65. India Nucleic Acid Based Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 66. Australia Nucleic Acid Based Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 67. Germany Nucleic Acid Based Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 68. France Nucleic Acid Based Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 69. UK Nucleic Acid Based Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 70. Italy Nucleic Acid Based Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 71. Russia Nucleic Acid Based Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 72. Spain Nucleic Acid Based Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 73. Egypt Nucleic Acid Based Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 74. South Africa Nucleic Acid Based Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 75. Israel Nucleic Acid Based Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 76. Turkey Nucleic Acid Based Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 77. GCC Countries Nucleic Acid Based Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 78. Global Nucleic Acid Based Gene Therapy Market Size Market Share Forecast by Type (2024-2029)
Figure 79. Global Nucleic Acid Based Gene Therapy Market Size Market Share Forecast by Application (2024-2029)
Figure 1. Nucleic Acid Based Gene Therapy Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Nucleic Acid Based Gene Therapy Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Nucleic Acid Based Gene Therapy Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Nucleic Acid Based Gene Therapy Sales Market Share by Country/Region (2022)
Figure 8. Nucleic Acid Based Gene Therapy Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Nucleic Acid Based Gene Therapy Market Size Market Share by Type in 2022
Figure 10. Nucleic Acid Based Gene Therapy in Hospitals and Clinics
Figure 11. Global Nucleic Acid Based Gene Therapy Market: Hospitals and Clinics (2018-2023) & ($ Millions)
Figure 12. Nucleic Acid Based Gene Therapy in Academic and Research Institutes
Figure 13. Global Nucleic Acid Based Gene Therapy Market: Academic and Research Institutes (2018-2023) & ($ Millions)
Figure 14. Nucleic Acid Based Gene Therapy in Others
Figure 15. Global Nucleic Acid Based Gene Therapy Market: Others (2018-2023) & ($ Millions)
Figure 16. Global Nucleic Acid Based Gene Therapy Market Size Market Share by Application in 2022
Figure 17. Global Nucleic Acid Based Gene Therapy Revenue Market Share by Player in 2022
Figure 18. Global Nucleic Acid Based Gene Therapy Market Size Market Share by Regions (2018-2023)
Figure 19. Americas Nucleic Acid Based Gene Therapy Market Size 2018-2023 ($ Millions)
Figure 20. APAC Nucleic Acid Based Gene Therapy Market Size 2018-2023 ($ Millions)
Figure 21. Europe Nucleic Acid Based Gene Therapy Market Size 2018-2023 ($ Millions)
Figure 22. Middle East & Africa Nucleic Acid Based Gene Therapy Market Size 2018-2023 ($ Millions)
Figure 23. Americas Nucleic Acid Based Gene Therapy Value Market Share by Country in 2022
Figure 24. United States Nucleic Acid Based Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 25. Canada Nucleic Acid Based Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 26. Mexico Nucleic Acid Based Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 27. Brazil Nucleic Acid Based Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 28. APAC Nucleic Acid Based Gene Therapy Market Size Market Share by Region in 2022
Figure 29. APAC Nucleic Acid Based Gene Therapy Market Size Market Share by Type in 2022
Figure 30. APAC Nucleic Acid Based Gene Therapy Market Size Market Share by Application in 2022
Figure 31. China Nucleic Acid Based Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 32. Japan Nucleic Acid Based Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 33. Korea Nucleic Acid Based Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 34. Southeast Asia Nucleic Acid Based Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 35. India Nucleic Acid Based Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 36. Australia Nucleic Acid Based Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 37. Europe Nucleic Acid Based Gene Therapy Market Size Market Share by Country in 2022
Figure 38. Europe Nucleic Acid Based Gene Therapy Market Size Market Share by Type (2018-2023)
Figure 39. Europe Nucleic Acid Based Gene Therapy Market Size Market Share by Application (2018-2023)
Figure 40. Germany Nucleic Acid Based Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 41. France Nucleic Acid Based Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 42. UK Nucleic Acid Based Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 43. Italy Nucleic Acid Based Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 44. Russia Nucleic Acid Based Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 45. Middle East & Africa Nucleic Acid Based Gene Therapy Market Size Market Share by Region (2018-2023)
Figure 46. Middle East & Africa Nucleic Acid Based Gene Therapy Market Size Market Share by Type (2018-2023)
Figure 47. Middle East & Africa Nucleic Acid Based Gene Therapy Market Size Market Share by Application (2018-2023)
Figure 48. Egypt Nucleic Acid Based Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 49. South Africa Nucleic Acid Based Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 50. Israel Nucleic Acid Based Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 51. Turkey Nucleic Acid Based Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 52. GCC Country Nucleic Acid Based Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 53. Americas Nucleic Acid Based Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 54. APAC Nucleic Acid Based Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 55. Europe Nucleic Acid Based Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 56. Middle East & Africa Nucleic Acid Based Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 57. United States Nucleic Acid Based Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 58. Canada Nucleic Acid Based Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 59. Mexico Nucleic Acid Based Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 60. Brazil Nucleic Acid Based Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 61. China Nucleic Acid Based Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 62. Japan Nucleic Acid Based Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 63. Korea Nucleic Acid Based Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 64. Southeast Asia Nucleic Acid Based Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 65. India Nucleic Acid Based Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 66. Australia Nucleic Acid Based Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 67. Germany Nucleic Acid Based Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 68. France Nucleic Acid Based Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 69. UK Nucleic Acid Based Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 70. Italy Nucleic Acid Based Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 71. Russia Nucleic Acid Based Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 72. Spain Nucleic Acid Based Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 73. Egypt Nucleic Acid Based Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 74. South Africa Nucleic Acid Based Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 75. Israel Nucleic Acid Based Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 76. Turkey Nucleic Acid Based Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 77. GCC Countries Nucleic Acid Based Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 78. Global Nucleic Acid Based Gene Therapy Market Size Market Share Forecast by Type (2024-2029)
Figure 79. Global Nucleic Acid Based Gene Therapy Market Size Market Share Forecast by Application (2024-2029)
